← Baja Ventures Group

Baja Ventures Group

DNA Testing Lab · Phase 2

1
DNA testing for TJ Med Spa patients
Portfolio Connection
Active

Provides fast turn-around DNA testing results to TJ Medical Spa patients, enabling personalized treatment plans and medication selection based on genetic profiles.

2
Tijuana plastic surgery corridor
Market Opportunity
Active

Serves premium plastic surgery clinics in Tijuana's premium surgery corridor (Chapultepec, Cacho). DNA analysis enables clinics to provide better recovery protocols tailored to their patients' genetic profiles.

3
DNA testing revenue model
Revenue Model
Active

DNA testing services for TJ Med Spa patients plus external plastic surgery clinic clients in the Chapultepec and Cacho corridors. Volume contracts with premium clinics.

4
Fast turnaround competitive advantage
Competitive Advantage
Active

Fast turn-around times vs US labs. Cost-effective pricing. Cross-border convenience. Same-day results available for TJ Med Spa patients.

5
Mexico regulatory flexibility for genetic testing
Regulatory Advantage
Phased

Mexico regulatory flexibility for genetic testing. Less restrictive than US FDA requirements for direct-to-consumer genetic analysis.

6
Geneticists and lab professionals
Leadership
Active

Geneticists and lab professionals with molecular biology expertise. PGVL corporate oversight.

7
Corporate structure
Corporate Structure
Active

US Reg D 506(c) under PGVL umbrella. Part of the Baja Ventures portfolio. HK parent company, MX local corporate S.A.

8
Investment growth chart
Investment Thesis
Phased

Portfolio exposure to all Baja ventures. Points in all projects. TBD ROI, disbursements 8 months post-launch.

Regulation D Rule 506(c) Disclosure

DNA Testing Lab · Baja Ventures Group Limited

Use of Funds — $300,000 Seed Raise

  • Corporate formation & legal (HK/MX/US)$45,000
  • Reg D 506(c) filing & compliance$25,000
  • Fundraising platform & investor portal$35,000
  • Marketing & investor outreach$50,000
  • Accounting & reporting systems$20,000
  • Working capital & admin reserves$75,000
  • Contingency$50,000
TOTAL$300,000
This seed capital is for corporate & infrastructure build-out ONLY — not for project purchases.
DNA Testing Lab Project Capex
  • Project capexTBD

Risk Factors

  • Investment involves significant risk. Investors may lose their entire investment.
  • $300K seed raise does not guarantee successful fundraising for DNA testing lab project capex.
  • Genetic testing requires specialized equipment, reagents, and certified personnel.
  • Cross-border operations subject to Mexican and US regulatory changes.
  • Genetic testing regulation may evolve, impacting service offerings.
  • No guaranteed ROI. Projected returns are estimates, not guarantees.
  • Liquidity is limited — no public market exists for these securities.
  • Key person risk — success depends on qualified geneticists and lab professionals.
  • Currency exchange risk between USD and MXN.
  • Competition from existing US-based genetic testing laboratories may impact revenue.

For Accredited Investors Only — Reg D 506(c) — Past performance is not indicative of future results.

This document is for informational purposes only and does not constitute an offer to sell or solicitation to buy securities.